Zai Lab Limited

21.81 USD
+1.01 (+4.86%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Zai Lab Limited stock is down -2.2% since 30 days ago. The next earnings date is May 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 6 February’s closed higher than January. In the last 3 Unusual Options Trades, there were 3 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Jan 18:55 20 Dec, 2024 30.00 PUT 100 431
07 Feb 15:55 15 Mar, 2024 22.50 PUT 100 172
09 Feb 15:42 15 Mar, 2024 22.50 PUT 99 273

About Zai Lab Limited

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia. It also develops Odronextamab, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer